Identifying and overcoming resistance to BCL2 inhibitors

Lead researcher

Dr Ian Majewski, Prof David Huang, Prof Andrew Roberts

Institution

The Walter and Eliza Hall Institute of Medical Research

Years funded

2017-2019

Our research is focused on a new family of drugs that target survival pathways that keep cancer cells alive. Our goal is to understand which patients will benefit the most from these treatments, and to determine why they fail in some cases.

Funding Body

Cancer Council Research Grant

Funding

$99,815 in 2017, $99,815 in 2018 and $99,692 in 2019

Updated: